. Author manuscript; available in PMC: 2012 Mar 1.

Published in final edited form as: Int J Mol Med. 2011 Jan 11;27(3):299–307. doi: 10.3892/ijmm.2011.597

Table I.

Body weights and blood glucose concentrations in non-diabetic and diabetic mice maintained with or without PMI-5011 treatment

Variables	Control	Control with PMI-5011	Diabetic	Diabetic with PMI-5011
Baseline (after induction of STZ-diabetes)
Body weight (g)	24.5±0.5		24.1±0.6
Blood glucose (mmol/l)	8.5±0.3		17.1±0.6^a
12-week time point (prior to interventions)
Body weight (g)	37.3±0.7	38.8±0.9	29.1±0.3^a	29.6±0.3^a
Blood glucose (mmol/l)	9.1±0.3	9.1±0.3	27.5±0.5^a	27.5±1.0^a
19-week time point (final measurements)
Body weight (g)	39.2±0.8	39.6±1.0	29.1±0.4^a	29.1±0.3^a
Blood glucose (mmol/l)	9.0±0.1	9.0±0.2	27.2±1.3^a	26.4±1.7^a

Data are expressed as mean ± SEM, n=18-20 per group.

P<0.01 vs. the non-diabetic controls.